Xttrium FDA Monday, December 24, 1984 0.00 Neutral

FDA Approves ANTISEPTIC SKIN CLEANSER — Xttrium Laboratories, Inc.

# FDA Approves Chlorhexidine Gluconate Antiseptic Skin Cleanser for Xttrium Laboratories Xttrium Laboratories, Inc. received FDA approval for its chlorhexidine gluconate topical antiseptic skin cleanser (NDA019125), positioning the company to capture market share in the broad antimicrobial skin preparation segment used across healthcare facilities and consumer markets. The approval establishes a foundational product line for Xttrium in the high-demand antiseptic category, where chlorhexidine-based formulations remain among the most widely

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day